Journal scope and general principles

European Annals of Allergy and Clinical Immunology (ISSN 1764-1489) is a bimonthly peer-reviewed publication.

As official Journal of the “Associazione Allergologi Immunologi Italiani Territoriali e Ospedalieri” (Association of Italian Hospital Allergists and Immunologists – AAIITO (www.aaiito.it)) and the “Sociedade Portuguesa de Alergologia e Imunologia Clinica” (Portuguese Society of Allergology and Clinical Immunology – SPAIC (www.spaic.pt)), it collects reviews and original works concerning etiology, diagnosis and treatment of allergic and immunological disorders. European Annals of Allergy and Clinical Immunology represents to the specialist a means for updating and widening in research and clinical practice field.

European Annals of Allergy and Clinical Immunology will accept for publication suitable manuscripts dealing with the aetiology, diagnosis and treatment of allergic and immunologic diseases. These might include the study of methods of controlling immunologic and allergic reactions, human and animal models of hypersensitivity and other aspects of basic and applied clinical allergy in its broadest sense. Paper reporting the results of drug trials will be considered.

European Annals of Allergy and Clinical Immunology also publishes solicited and usolicited review articles on subjects of topical interest to clinical and experimental allergy.

Manuscripts are considered for publication with the understanding that they do not contain previously published material, have not been published previously and are not currently under review at another journal.

If the manuscript is accepted for publication in European Annals of Allergy and Clinical Immunology, the authors guarantee that it will not be published elsewhere in any other language without permission from the copyright holder.

The authors of manuscripts that include illustrations, tables and/or sections of text that have been published previously elsewhere must request permission to reproduce the material from the copyright holder. This permission must be presented in written form during submission of the manuscript. In the absence of such permission, all material received will be regarded as the authors’ own work.

Manuscripts that report the results of research conducted on human subjects must include a declaration in the Materials and methods section that the study protocol was approved by the competent Ethics Committee, that the study was conducted in accordance with the ethical standards established in the Declaration of Helsinki of 1946 (World Medical Association. World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA 2013 Nov 27;310(20):2191-4. doi: 10.1001/jama.2013.281053), and that informed consent was obtained from all participants before enrolment in the study. All details that could reveal the identity of a patient (including initials of the patient name and unnecessary reference to personal data such as occupation and residence) must be omitted from the text and illustrative materials.

If experiments have been conducted on animals, the study must have been conducted in accordance with the International Animal Research Regulations (Institute of Medicine (US); National Research Council (US). International Animal Research Regulations: Impact on Neuroscience Research: Workshop Summary. Washington (DC): National Academies Press (US); 2012. doi: 10.17226/13322) and such adherence must be explicitly stated in the manuscript.

The decision to publish a manuscript is based on a double blind peer-review process, and acceptance of an article will be based on criteria of originality, relevance, and scientific content of the contribution. The authors may be requested to modify the text based on the comments of reviewers. Statements made in the manuscripts are the responsibility of the author and not of the editor. The opinions expressed in the articles are those of the authors and may not reflect the position of the editors.

Authorship criteria

Authorship is a way of making explicit both credit and responsibility for the contents of published articles. Please note that to qualify for authorship an individual should meet all of the following criteria:

  1. Substantial contributions to conception and design, or acquisition of data, or analysis and interpretation of data; AND
  2. Drafting the article or revising it critically for important intellectual content; AND
  3. Final approval of the version to be published; AND
  4. Agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.

Contributors who do not qualify for authorship should be included in the ‘Acknowledgements’ section.

Authors are required to confirm during the submission process that all individuals that qualified for authorship have been included (to prevent ghost authorship) and that all those included qualify for authorship (to prevent gift/guest authorship).

For more information see ICMJE’s “Defining the Role of Authors and Contributors” webpage: http://www.icmje.org/recommendations/browse/roles-and-responsibilities/defining-the-role-of-authors-and-contributors.html.

Order of authorship

The authors themselves should decide the order in which authors are listed in an article. Many different criteria are used to decide order of authorship. Among these are relative contributions to the work and, in situations where all authors have contributed equally, alphabetical or random order. Readers cannot know, and should not assume, the meaning of order of authorship unless the approach to assigning order has been described by the authors.

Change in authorship

If the list of authors needs to be amended after submission, a letter explanation should be prepared, hand-signed (print-sign-scan procedure) by all authors including the author that is to be added/removed/shifted, and sent to editorialoffice@eur-ann-allergy-clin-immunol.com.

European Annals of Allergy and Clinical Immunology ISSN 1764-1489 | © 2024